New possibilities in medicine delivery.
Nortiva Bio offers a proprietary, long-acting oral drug delivery platform that transforms standard oral therapies into once‑weekly or monthly pills.
LYNX™ DRUG DELIVERY PLATFORM
An innovative technology to replace daily pills.
The LYNX™ platform can help drugs improve:
Efficacy &
safety
LYNX delivers a stable dose at target levels, reducing the risk of side effects from the peaks and troughs of daily administration.
Adherence & convenience
Research has shown consistent advantages of less-frequent dosing with improved adherence and patient experience.
Competitive differentiation
Nortiva’s platform is the only clinically validated technology for long acting oral dosing.
Clinically validated technology
Tested in multiple human and animal trials with compelling safety, tolerability, and dose release profiles across indications.
100+
doses in humans
1000+
doses in animals
PARTNER WITH NORTIVA